Concise Review: Mesenchymal Stem Cells: From Roots to Boost
Top Cited Papers
Open Access
- 12 April 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 37 (7), 855-864
- https://doi.org/10.1002/stem.3016
Abstract
It was shown as long as half a century ago that bone marrow is a source of not only hematopoietic stem cells, but also stem cells of mesenchymal tissues. Then the term “mesenchymal stem cells” (MSCs) was coined in the early 1990s, and more than a decade later, the criteria for defining MSCs have been released by the International Society for Cellular Therapy. The easy derivation from a variety of fetal and adult tissues and undemanding cell culture conditions made MSCs an attractive research object. It was followed by the avalanche of reports from preclinical studies on potentially therapeutic properties of MSCs, such as immunomodulation, trophic support and capability for a spontaneous differentiation into connective tissue cells, and differentiation into the majority of cell types upon specific inductive conditions. Although ontogenesis, niche, and heterogeneity of MSCs are still under investigation, there is a rapid boost of attempts at clinical applications of MSCs, especially for a flood of civilization‐driven conditions in so quickly aging societies, not only in the developed countries, but also in the populous developing world. The fields of regenerative medicine and oncology are particularly extensively addressed by MSC applications, in part due to the paucity of traditional therapeutic options for these highly demanding and costly conditions. There are currently almost 1,000 clinical trials registered worldwide at ClinicalTrials.gov, and it seems that we are starting to witness the snowball effect with MSCs becoming a powerful global industry; however, the spectacular effects of MSCs in the clinic still need to be shown. Stem Cells 2019;37:855–864Keywords
Funding Information
- National Institutes of Health (NIH R01 NS091100-01A1)
- NCR&D (EXPLORE ME)
- National Institutes of Health (NIH R01 NS091100‐01A1)
This publication has 101 references indexed in Scilit:
- Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSCCell Communication and Signaling, 2011
- Dual origin of mesenchymal stem cells contributing to organ growth and repairProceedings of the National Academy of Sciences of the United States of America, 2011
- Bone marrow stromal cells inhibit mast cell function via a COX2‐dependent mechanismClinical & Experimental Allergy, 2011
- Mesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor HStem Cells and Development, 2010
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Mesenchymal Stem Cells: Revisiting History, Concepts, and AssaysCell Stem Cell, 2008
- Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblastsAging Cell, 2008
- Endometrial regenerative cells: A novel stem cell populationJournal of Translational Medicine, 2007
- Adipocyte differentiation from the inside outNature Reviews Molecular Cell Biology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006